CHAT
Choline O-acetyltransferase
Also known as: CLAT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28329
- Gene
- CHAT
- Ensembl
- ENSG00000070748
- Chromosome
- 10
- Canonical length
- 748 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
748 residues, UniProt reviewed canonical sequence.
>P28329|CHAT
1 MGLRTAKKRG LGGGGKWKRE EGGGTRGRRE VRPACFLQSG GRGDPGDVGG PAGNPGCSPH
61 PRAATRPPPL PAHTPAHTPE WCGAASAEAA EPRRAGPHLC IPAPGLTKTP ILEKVPRKMA
121 AKTPSSEESG LPKLPVPPLQ QTLATYLQCM RHLVSEEQFR KSQAIVQQFG APGGLGETLQ
181 QKLLERQEKT ANWVSEYWLN DMYLNNRLAL PVNSSPAVIF ARQHFPGTDD QLRFAASLIS
241 GVLSYKALLD SHSIPTDCAK GQLSGQPLCM KQYYGLFSSY RLPGHTQDTL VAQNSSIMPE
301 PEHVIVACCN QFFVLDVVIN FRRLSEGDLF TQLRKIVKMA SNEDERLPPI GLLTSDGRSE
361 WAEARTVLVK DSTNRDSLDM IERCICLVCL DAPGGVELSD THRALQLLHG GGYSKNGANR
421 WYDKSLQFVV GRDGTCGVVC EHSPFDGIVL VQCTEHLLKH VTQSSRKLIR ADSVSELPAP
481 RRLRWKCSPE IQGHLASSAE KLQRIVKNLD FIVYKFDNYG KTFIKKQKCS PDAFIQVALQ
541 LAFYRLHRRL VPTYESASIR RFQEGRVDNI RSATPEALAF VRAVTDHKAA VPASEKLLLL
601 KDAIRAQTAY TVMAITGMAI DNHLLALREL ARAMCKELPE MFMDETYLMS NRFVLSTSQV
661 PTTTEMFCCY GPVVPNGYGA CYNPQPETIL FCISSFHSCK ETSSSKFAKA VEESLIDMRD
721 LCSLLPPTES KPLATKEKAT RPSQGHQPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHAT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 5.1 nTPM
Expression across tissuesHPA
Tissue
- placenta: 5.1 nTPM
- basal ganglia: 3.7 nTPM
- retina: 0.8 nTPM
- duodenum: 0.7 nTPM
- hypothalamus: 0.5 nTPM
- small intestine: 0.5 nTPM
Single-cell type
- tuft cells: 404 nCPM
- other brain neurons: 28 nCPM
- retinal amacrine cells: 27 nCPM
- fibroblasts: 5.9 nCPM
- early spermatids: 3.7 nCPM
- early primary spermatocytes: 1.7 nCPM
Immune cell
- memory CD4 T-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 40 nTPM
- pons: 22 nTPM
- medulla oblongata: 18 nTPM
- midbrain: 12 nTPM
- hypothalamus: 7.6 nTPM
- basal ganglia: 6.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHAT.
Disease | AllUniProt
Conditions CHAT is implicated in, by any mechanism.
- Myasthenic syndrome, congenital, 6, presynaptic (CMS6) MIM:254210
Disease | GeneticClinVar
110 pathogenic / likely-pathogenic of 1,074 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Familial infantile myasthenia
- Congenital myasthenic syndrome
- 11 conditions
- Congenital myasthenic syndrome 4C
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.3
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acetylcholine biosynthetic process
- neuromuscular synaptic transmission
- neurotransmitter transport
- phosphatidylcholine biosynthetic process
Molecular functions
- choline O-acetyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHAT as an antibody target. Whether an autoantibody or antibody against CHAT could matter depends on whether native CHAT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHAT is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHAT as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...